SAN FRANCISCO, Dec. 28, 2016 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that members of the company's management team will present at the 35th Annual J.P. Morgan Healthcare conference on Wednesday, January 11, 2017 at 2:30 p.m. Pacific at The Westin St. Francis in San Francisco.
The live, listen-only webcast of both the presentation and breakout session immediately following may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company's website.
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. For more information, visit our website at invitae.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/invitae-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300383750.html
SOURCE Invitae Corporation